Subtopic Deep Dive
Core Decompression
Research Guide
What is Core Decompression?
Core decompression is a surgical procedure that drills channels into the femoral head to relieve pressure and promote revascularization in early-stage osteonecrosis of the femoral head (ONFH).
Studies compare core decompression alone or with adjuncts like autologous bone marrow grafting against nonoperative management, showing superior pain relief and hip survival rates (Mont et al., 1996; 535 citations). Hernigou and Beaujean (2002; 638 citations) demonstrated 82% success with marrow grafting in pre-collapse stages. Over 40 reports analyzed 2025 hips, favoring intervention in early stages (Mont et al., 1996).
Why It Matters
Core decompression delays total hip arthroplasty in young patients, preserving native joint function; Hernigou and Beaujean (2002) reported 10-year survival rates up to 82% with marrow grafting versus 40-50% for decompression alone. In sickle cell disease, it manages avascular necrosis complications (Almeida and Roberts, 2005; 437 citations). Moya-Angeler (2015; 508 citations) notes it accounts for 10% of 250,000 annual US hip replacements, guiding minimally invasive options. Zalavras and Lieberman (2014; 382 citations) highlight risk factor mitigation like corticosteroids.
Key Research Challenges
Stage-Dependent Efficacy
Outcomes decline in advanced Ficat stages; Mont et al. (1996; 535 citations) found 75% success in early stages but only 32% in late stages across 1206 hips. Long-term collapse prevention remains inconsistent (Scully et al., 1998; 247 citations).
Optimal Adjunct Selection
Unclear which grafts outperform standard decompression; Hernigou et al. (2005; 301 citations) showed autologous marrow benefits nonunion but head-to-head trials lack (Petek et al., 2019; 369 citations). Variability in marrow concentration affects revascularization.
Pathophysiology Targeting
Glucocorticoid-induced apoptosis drives ONFH (Weinstein et al., 2000; 377 citations), but decompression does not fully address osteocyte death. Shah et al. (2015; 295 citations) identify multifactorial risks complicating targeted therapies.
Essential Papers
Treatment of Osteonecrosis With Autologous Bone Marrow Grafting
Philippe Hernigou, F. Beaujean · 2002 · Clinical Orthopaedics and Related Research · 638 citations
Core decompression with bone graft is used frequently in the treatment of osteonecrosis of the femoral head. Many different techniques have been described. In the current series, grafting was done ...
Core Decompression Versus Nonoperative Management for Osteonecrosis of the Hip
Michael A. Mont, John J. Carbone, Adrian C. Fairbank · 1996 · Clinical Orthopaedics and Related Research · 535 citations
A complete review of the literature disclosed that there were 42 reports of 2025 hips treated by either core decompression (1206 hips) or nonoperative management (819 hips), excluding electrical st...
Current concepts on osteonecrosis of the femoral head
Joaquín Moya-Angeler · 2015 · World Journal of Orthopedics · 508 citations
It is estimated that 20000 to 30000 new patients are diagnosed with osteonecrosis annually accounting for approximately 10% of the 250000 total hip arthroplasties done annually in the United States...
Bone involvement in sickle cell disease
António Almeida, Irene Roberts · 2005 · British Journal of Haematology · 437 citations
Summary Bone involvement is the commonest clinical manifestation of sickle cell disease both in the acute setting such as painful vaso‐occlusive crises, and as a source of chronic, progressive disa...
Osteonecrosis of the Femoral Head
Charalampos G. Zalavras, Jay R. Lieberman · 2014 · Journal of the American Academy of Orthopaedic Surgeons · 382 citations
Osteonecrosis of the femoral head may lead to progressive destruction of the hip joint. Although the etiology of osteonecrosis has not been definitely delineated, risk factors include corticosteroi...
Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip<sup>1</sup>
Robert S. Weinstein, Richard W. Nicholas, Stavros C. Manolagas · 2000 · The Journal of Clinical Endocrinology & Metabolism · 377 citations
An increase in osteoblast and osteocyte apoptosis has been demonstrated in mice and humans receiving glucocorticoids and may be involved in the pathogenesis of the associated osteonecrosis. To exam...
Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment
Daniel Petek, Didier Hannouche, Domizio Suvà · 2019 · EFORT Open Reviews · 369 citations
Osteonecrosis of the femoral head is a disabling pathology affecting a young population (average age at treatment, 33 to 38 years) and is the most important cause of total hip arthroplasty in this ...
Reading Guide
Foundational Papers
Start with Mont et al. (1996; 535 citations) for core decompression vs nonoperative benchmark on 2025 hips, then Hernigou and Beaujean (2002; 638 citations) for grafting technique establishing 82% success baseline.
Recent Advances
Petek et al. (2019; 369 citations) for pathophysiology updates; Shah et al. (2015; 295 citations) risk factors; Moya-Angeler (2015; 508 citations) for epidemiology.
Core Methods
Multiple drilling (Mont 1996), autologous marrow injection (Hernigou 2002, 2005), vascularized grafting (Scully 1998); assessed via survival analysis and Harris hip scores.
How PapersFlow Helps You Research Core Decompression
Discover & Search
Research Agent uses citationGraph on Hernigou and Beaujean (2002; 638 citations) to map 300+ citing works on marrow-augmented decompression, then findSimilarPapers for stage-specific trials. exaSearch queries 'core decompression survival rates Ficat stage II' retrieving 50+ OpenAlex papers beyond lists. searchPapers filters by orthopedics journals post-2015.
Analyze & Verify
Analysis Agent applies readPaperContent to Mont et al. (1996) for meta-analysis of 2025 hips, then runPythonAnalysis with pandas to compute pooled survival rates (e.g., 52% decompression vs. 24% nonoperative). verifyResponse via CoVe cross-checks claims against Weinstein et al. (2000) apoptosis data; GRADE grading scores evidence as moderate for early-stage efficacy.
Synthesize & Write
Synthesis Agent detects gaps like adjunct comparisons via contradiction flagging across Hernigou (2002) and Scully (1998), generating exportMermaid flowcharts of treatment pathways. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations integrating 10 core papers, and latexCompile for camera-ready review with survival Kaplan-Meier figures.
Use Cases
"Run survival analysis on core decompression datasets from key trials"
Research Agent → searchPapers 'core decompression survival' → Analysis Agent → readPaperContent (Mont 1996, Scully 1998) → runPythonAnalysis (pandas Kaplan-Meier curves on 2025 hips data) → matplotlib plot of hazard ratios.
"Draft LaTeX review comparing decompression vs grafting for ONFH"
Synthesis Agent → gap detection (Hernigou 2002 vs Mont 1996) → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (10 papers) → latexCompile (PDF with tables) → output polished 20-page systematic review.
"Find code for finite element modeling of femoral head decompression"
Research Agent → searchPapers 'core decompression FEM simulation' → paperExtractUrls → paperFindGithubRepo (biomech repos) → githubRepoInspect → runPythonAnalysis (NumPy stress models) → researcher gets validated simulation scripts.
Automated Workflows
Deep Research workflow scans 50+ ONFH papers via citationGraph from Hernigou (2002), producing GRADE-scored systematic review with survival meta-analysis. DeepScan's 7-step chain verifies Petek et al. (2019) pathophysiology claims against Weinstein (2000) using CoVe checkpoints. Theorizer generates hypotheses on marrow dosing from Hernigou series, exporting Mermaid theory diagrams.
Frequently Asked Questions
What is core decompression?
Core decompression drills channels into the femoral head to reduce intraosseous pressure and induce revascularization in early ONFH (Mont et al., 1996).
What are main methods?
Standard drilling versus adjuncts like autologous bone marrow grafting (Hernigou and Beaujean, 2002; 638 citations) or vascularized fibula (Scully et al., 1998).
What are key papers?
Hernigou and Beaujean (2002; 638 citations) on marrow grafting; Mont et al. (1996; 535 citations) meta-analysis of 2025 hips; Moya-Angeler (2015; 508 citations) concepts review.
What are open problems?
Optimal adjuncts for late stages, long-term survival predictors, and addressing apoptosis (Weinstein et al., 2000; Shah et al., 2015).
Research Bone and Joint Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Core Decompression with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Bone and Joint Diseases Research Guide